Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–807. https://doi.org/10.1016/S0140-6736(09)60553-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ülger P, Yildiz E, Tyczynski B, Findeisen H, Kribben A, Janssen OE, et al. Effect of stress hyperglycaemia on acute kidney injury in non-diabetic critically ill patients? Int Urol Nephrol. 2023;55(12):3253–9. https://doi.org/10.1007/s11255-023-03612-2.

Article  CAS  PubMed  Google Scholar 

Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol. 2011;75(1):26–33.

CAS  PubMed  Google Scholar 

Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011;15(2):221. https://doi.org/10.1186/cc10021.

Article  PubMed  PubMed Central  Google Scholar 

Alipoor E, Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ. Adipokines in critical illness: a review of the evidence and knowledge gaps. Biomed Pharmacother. 2018;108:1739–50. https://doi.org/10.1016/j.biopha.2018.09.165.

Article  CAS  PubMed  Google Scholar 

Lehrke M, Broedl UC, Biller-Friedmann IM, Vogeser M, Henschel V, Nassau K, et al. Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions. Crit Care. 2008;12(6):R157. https://doi.org/10.1186/cc7152.

Article  PubMed  PubMed Central  Google Scholar 

Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den Berghe G. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care. 2009;13(4):R112. https://doi.org/10.1186/cc7956.

Article  PubMed  PubMed Central  Google Scholar 

Saberi F, Heyland D, Lam M, Rapson D, Jeejeeghoy K. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr. 2008;32(3):227–35. https://doi.org/10.1177/0148607108316195.

Article  CAS  PubMed  Google Scholar 

Jernås M, Olsson B, Sjöholm K, Sjögren A, Rudemo M, Nellgård B, et al. Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness. Metabolism. 2009;58(1):102–8. https://doi.org/10.1016/j.metabol.2008.08.012.

Article  CAS  PubMed  Google Scholar 

Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, Lan YF, et al. Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway. J Cell Physiol. 2012;227(1):239–49. https://doi.org/10.1002/jcp.22726.

Article  CAS  PubMed  Google Scholar 

Tsugawa-Shimizu Y, Fujishima Y, Kita S, Minami S, Sakaue TA, Nakamura Y, et al. Increased vascular permeability and severe renal tubular damage after ischemia-reperfusion injury in mice lacking adiponectin or T-cadherin. Am J Physiol Endocrinol Metab. 2021;320(2):E179–90. https://doi.org/10.1152/ajpendo.00393.2020.

Article  CAS  PubMed  Google Scholar 

Jin X, Chen J, Hu Z, Chan L, Wang Y. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int. 2013;83(4):604–14. https://doi.org/10.1038/ki.2012.408

Article  CAS  Google Scholar 

Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burmann EA, Goldstein SL, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(Suppl. 1):S1-138. https://doi.org/10.1038/kisup.20125.

Article  Google Scholar 

Billings FT, Shaw AD. Clinical trial endpoints in acute kidney injury. Nephron Clin Pract. 2014;127(1–4):89–93. https://doi.org/10.1159/000363725.

Article  CAS  PubMed  Google Scholar 

Matthew W, Semler Wesley H, Self Jonathan P, Wanderer Jesse M, Ehrenfeld Li, Wang Daniel W, Byrne Joanna L, Stollings Avinash B, Kumar Christopher G, Hughes Antonio, Hernandez Oscar D, Guillamondegui Addison K, May Liza, Weavind Jonathan D, Casey Edward D, Siew Andrew D, Shaw Gordon R, Bernard Todd W, Rice . Balanced Crystalloids versus Saline in Critically Ill Adults New England Journal of Medicine. 2018;378:(9) 829–839 https://doi.org/10.1056/NEJMoa1711584

Article  PubMed  Google Scholar 

Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–95. https://doi.org/10.2337/diacare.27.6.1487.

Article  PubMed  Google Scholar 

Vassiliadi DA, Tzanela M, Kotanidou A, Orfanos SE, Nikitas N, Armaganidis A, et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: association with sepsis phase, severity, and circulating cytokine levels. J Crit Care. 2012;27(4):400–9. https://doi.org/10.1016/j.jcrc.2012.04.007.

Article  CAS  PubMed  Google Scholar 

Zauner A, Nimmerrichter P, Anderwald C, Bischof M, Schiefermeier M, Ratheiser K, et al. Severity of insulin resistance in critically ill medical patients. Metabolism. 2007;56(1):1–5. https://doi.org/10.1016/j.metabol.2006.08.014.

Article  CAS  PubMed  Google Scholar 

Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100. https://doi.org/10.1093/jmcb/mjw011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carballo MC, Pinto LC, Brito MV. The role of adiponectin in ischemia-reperfusion syndrome: a literature review. Einstein (Sao Paulo). 2020;18:eRW5160. https://doi.org/10.31744/einstein_journal/2020rw5160.

Article  PubMed  Google Scholar 

Yue H, Zhang Q, Chang S, Zhao X, Wang M, Li W. Adiponectin protects against myocardial ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical animal studies. Lipids Health Dis. 2024;23(1):51. https://doi.org/10.1186/s12944-024-02028-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schünemann H, Hill S, Guyatt G, Akl EA, Ahmed F. The GRADE approach and Bradford Hill’s criteria for causation. J Epidemiol Community Health. 2011;65(5):392–5. https://doi.org/10.1136/jech.2010.119933.

Article  PubMed  Google Scholar 

Lazzeri C, Valente S, Chiostri M, Attanà P, Mattesini A, Gensini GF. Acute insulin resistance assessed by the homeostatic model assessment in acute coronary syndromes without previously known diabetes. Angiology. 2014;65(6):519–24. https://doi.org/10.1177/000331971348901.

Article  PubMed  Google Scholar